Label Changes for:

Micronase (glyburide) tablets

February 2011

Changes have been made to the ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – February 2011

 

Risk of Hepatic Failure Label Changes for Sulfonylurea's

  • Diabinese (chlorpropamide) tablets
  • Micronase (glyburide) tablets
  • Metaglip (glipizide/metformin HCl fixed-dose combination) tablets
  • Glucotrol and Glucotrol XL (glipizide) tablets
  • Glynase (micronized glyburide) tablets

 

ADVERSE REACTIONS

  • Cholestatic jaundice and hepatitis may occur rarely which may progress to liver failure; The drug should be discontinued if this occurs.
Hide
(web4)